Presenter: Tamara Ooms, RN, MS, FNP
Online CME Credit
Fee: Free
Provides 1.00 hours of CE/CME credit (Presented: August 28, 2023; Reviewed July 1, 2024; Expires June 30, 2025)
Presenter: Tamara Ooms, RN, MS, FNP
Online CME Credit
Fee: Free
Provides 1.00 hours of CE/CME credit (Presented: August 28, 2023; Reviewed July 1, 2024; Expires June 30, 2025)
This recording is in collaboration with the California Prevention Training Center and the Pacific AIDS Education and Training Center-Nevada. Doxy-PEP stands for doxycycline post-exposure prophylaxis. It involves taking one 200mg pill of doxycycline, a kind of tetracycline, as soon as possible but no later than three days after having sex without a condom. It is a sexual health strategy in which people who have a history of sexually transmitted infections (STIs) take doxycycline after condomless sex, and is highly effective at preventing STIs. This webinar will summarize data from studies on doxy PEP, explore individual and population concerns surrounding doxy PEP, and compare strategies and implementation in clinical settings.
Following participation in this course, participants should be able to:
The Pacific AETC-NV offers engaging and interactive online learning opportunities to increase healthcare providers' knowledge and awareness of HIV and STI-related health topics. To view all session topics available, please click on Pacific AETC Nevada’s E-Learning page for more online and on-demand learning opportunities.
Tamara Ooms, RN, MS, FNP
Clinical Faculty and Program Manager
California Prevention Training Center
UCSF Bixby Center for Global Reproductive Health
Tamara Ooms, is a nurse practitioner by training. She is clinical faculty and program manager for the California Prevention Training Center. Tamara has worked in sexual and reproductive health for over twenty years as a clinician, educator and administrator. She is a member of the volunteer faculty for the University of California, San Francisco School of Nursing and she provides clinical care to patients at the municipal STI clinic in Portland, Oregon, where she currently lives.
The Pacific AETC is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award $3,887,700.00. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov.
Please follow the link to register with the Pacific AETC Nevada’s E-Learning program. In order to continue funding and provide educational programming for health professionals around HIV/AIDS, we need all participants to register through PAETC-NV.
This webinar requires you to login into the University of Nevada, Reno School of Medicine, Office of Continuing Medical Education’s (UNR Med CME) website to complete your registration. If you do not have a UNR Med CME account, you will need to make one.
Once you have signed into the UNR Med CME websites, follow the instructions below to watch the webinar and collect your CME, CE, and pharmacy credit.
If you have any questions, please email us at paetcnv@med.unr.edu.
For questions concerning the online evaluation or your certificate, please contact our office at (775) 784-4791 or email us at cme@med.unr.edu.
The University of Nevada, Reno School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Nevada, Reno School of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The University of Nevada, Reno School of Medicine approves this program for 1.00 hours of nursing continuing education credit.
As an accredited provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME) the University of Nevada, Reno School of Medicine must ensure balance, independence, objectivity, and scientific rigor in all its educational activities. In order to assure that information is presented in a scientific and objective manner, The University of Nevada, Reno School of Medicine requires that anyone in a position to control or influence the content of an accredited activity disclose all financial relationships within the prior 24 months with any commercial or proprietary entity producing health care goods or services relevant to the content being planned or presented. All relevant financial relationships have been mitigated. Following are those disclosures.
All other presenters, planners or anyone in a position to control the content of this continuing medical education activity have indicated that they do not have financial relationships with ineligible companies related to the content of this activity.
Kelley, Colleen. (2022). DoxyPEP and the Gut Microbiome. Panel: Prepping for Doxycycline Post Exposure Prophylaxis: Considerations for Public Health Implementation. 2022 STD Prevention Conference. Virtual.
Luetkemeyer, AF et al., (2023). Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections. New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMoa2211934
Luetkemeyer A et al (2023). DOXYPEP and antimicrobial resistance in N. Gonorrhoee, commensal Neisseria and S. Aureus. Conference on Retroviruses and Opportunistic Infections. Abstract 120. CROI 2023, Seattle, WA. https://www.croiconference.org/abstract/doxypep-antimicrobial-resistance-in-n-gonorrhoeae-commensal-neisseria-s-aureus
Molina, JM et al., (2018). Post Exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open –label randomised substudy of the ANRS IPERGAY trial. Lancet Infectious Diseases https://doi.org/10.1016/S1473-3099(17)30725-9
Molina JM, Bercot B, Assoumou A, et al (2023). ANRS 174 DOXYVAC: an open-label randomized trial to prevent STIs in MSM on PrEP. 30th Conference on Retroviruses and Opportunistic Infections, Abstract 119. CROI 2023, Seattle, WA. URL: https://www.croiconference.org/abstract/anrs-174-doxyvac-an-open-label-randomized-trial-to-prevent-stis-in-msm-on-prep
Stewart J et al (2023). Doxycycline postexposure prophylaxis for prevention of STIs among cisgender women.
30th Conference on Retroviruses and Opportunistic Infections,. Abstract 121. CROI 2023, Seattle, WA.
https://www.croiconference.org/abstract/doxycycline-postexposure-prophylaxis-for-prevention-of-stis-among-cisgender-women
Stewart J et al. (2023) Self-reported adherence to event-driven doxycycline postexposure prophylaxis for sexually transmitted infection prevention among cisgender women. STI & HIV 2023 World Congress. 2023, Chicago, IL.